[1]
Pawan Trivedi and Priyanka Singh, “Is a Five Marker Panel with Basal Marker Expression (EGFR and/or CK5/6) Superior to a Three Marker Panel in Predicting Prognosis in Molecular Subtypes of Breast Carcinoma? A Comparative Study”, RDMMR-V11, pp. 7–16, Oct. 2021.